Back to Agenda
[V5-S2] How to Provide Drug Information from a Standpoint of a Patient (Part 1)
Session Chair(s)
Yuko Kojima, RPH
Sr. Executive Director, Eli Lilly Japan K.K., Japan
Mamoru Narukawa, PHD, RPH
Professor, Kitasato University, Japan
Speaker(s)
Tomoko Tanita
Risk Communication Promotion Division, Office of Safety I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
The Regulations of Drug Information Provision and its Challenges - From the Regulatory Agencies' Perspective
Junichi Nishino, MSC, RPH
Head, Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd., Japan
The Current Status and the Issue of Drug Information Provision from the Pharmaceutical Industry Perspective
Masahiro Hayashi, PHD
Pharmaceutical affairs specialist, Department of Pharmacy, Toranomon Hospital, Japan
The Current Status of the Providing Drug Information and Issue of the Medical Communication - The Point of View from Medical Site
Have an account?
